A Win For VIVUS, Inc.
Wed, Feb 05, 2020 at 05:30 PM
VIVUS, Inc. (VVUS:NASDAQ) jumped higher at $3.38, a gain of 47%. The stock appeared on our News Catalysts scanner on Wed 05 Feb 20 at 08:09 AM in the 'RECOMMENDATION' category. From Tue 14 Jan 20, the stock recorded 42.86% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About VIVUS, Inc. (VVUS:NASDAQ)
VIVUS Incis a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets. Its product line includes Qsymia for sleep apnea, STENDRA for erectile dysfunction.
Top 10 Gainers:
- SenesTech, Inc. (SNES:NASDAQ), 1854.44%
- Myomo, Inc. (MYO:NYSEMKT), 88.61%
- VIVUS, Inc. (VVUS:NASDAQ), 46.96%
- Puma Biotechnology, Inc. (PBYI:NASDAQ), 37.67%
- Huitao Technology Co., Ltd. (HHT:NASDAQ), 34.61%
- Wah Fu Education Group Limited (WAFU:NASDAQ), 34.24%
- Greenhill & Co., Inc. (GHL:NYSE), 29.15%
- FTS International, Inc. (FTSI:NYSE), 29.11%
- CONSOL Energy Inc. (CEIX:NYSE), 26.59%
- Peabody Energy Corporation (BTU:NYSE), 25.64%